NDC 48433-328-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-328
- Requested NDC
- 48433-328-01
- Package NDCs from labels
- 48433-328-01, 48433-328-10
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2014-08-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Safecor Health, LLC | Safecor Health, LLC | 2014-08-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | GABAPENTIN CAPSULE [SAFECOR HEALTH, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Tawny | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 52c3378f-6b99-42fa-900e-8a693864c615 | 2021-06-29 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals of New York LLC | b11dbff5-ceee-4a63-a093-f6efebdc2f6f | 2021-02-03 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c79d94ec-117d-4fb6-845d-1954e3472bb0 | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gaba 300-EZS | GABAPENTIN | PureTek Corporation | bb29692e-1546-4d05-a46a-93baf4172c7d | 2020-11-16 | Warnings, Adverse reactions | 310431 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 3b4395f2-9440-4b67-97cc-5d16f3bdd05e | 2020-08-14 | Warnings, Adverse reactions | ANDA078787 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 39149f0e-30ed-4671-8be7-2a484f65d63b | 2020-08-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ded42b88-94dd-462d-bcdf-7fd34d1e49c3 | 2020-07-01 | Warnings, Adverse reactions | ANDA078787 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 45039bba-7a96-450c-95be-83a3aa4fcbd2 | 2020-06-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 8b2f38ef-0a0c-45cc-88ca-cc086bf80641 | 2020-06-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | ba2a8352-5776-4edb-914e-ce1d18ccda32 | 2020-05-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c09c66fd-cb31-41dd-b00b-acc58bd809f7 | 2020-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 7d77dae0-df76-4b7b-9690-713e9a60e3cd | 2019-12-01 | Warnings, Adverse reactions | ANDA078787 310430 6CW7F3G59X |
| 2c63468b-b8af-4d44-99ba-71e7e4742e2c | 0c27d406-45de-4df0-8db0-c3d654fe7637 | 2019-11-23 | Warnings, Adverse reactions | 0c27d406-45de-4df0-8db0-c3d654fe7637 | ||
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 4bae5032-f634-4d1e-b672-8a7e2bd6a5fa | 2019-11-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 92c4d589-533b-4fe4-833f-dd68cc1f7e66 | 2019-11-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2ef99c3d-866a-438b-a340-8beba8d4c457 | 2019-11-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.